User profiles for "author:Marc Lipsitch"

Marc Lipsitch

Department of Epidemiology, Harvard School of Public Health
Verified email at hsph.harvard.edu
Cited by 64752

[HTML][HTML] SARS-CoV-2 breakthrough infections in vaccinated individuals: measurement, causes and impact

M Lipsitch, F Krammer, G Regev-Yochay… - Nature Reviews …, 2022 - nature.com
Breakthrough infections with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) in fully vaccinated individuals are receiving intense scrutiny because of their importance …

Serotype replacement in disease after pneumococcal vaccination

DM Weinberger, R Malley, M Lipsitch - The Lancet, 2011 - thelancet.com
Vaccination with heptavalent pneumococcal conjugate vaccine (PCV7) has significantly
reduced the burden of pneumococcal disease and has had an important public health …

Antibiotics in agriculture and the risk to human health: how worried should we be?

Q Chang, W Wang, G Regev‐Yochay… - Evolutionary …, 2015 - Wiley Online Library
The use of antibiotics in agriculture is routinely described as a major contributor to the
clinical problem of resistant disease in human medicine. While a link is plausible, there are …

[HTML][HTML] BNT162b2 mRNA Covid-19 vaccine in a nationwide mass vaccination setting

N Dagan, N Barda, E Kepten, O Miron… - … England Journal of …, 2021 - Mass Medical Soc
Background As mass vaccination campaigns against coronavirus disease 2019 (Covid-19)
commence worldwide, vaccine effectiveness needs to be assessed for a range of outcomes …

[HTML][HTML] Covid-19 breakthrough infections in vaccinated health care workers

M Bergwerk, T Gonen, Y Lustig, S Amit… - … England Journal of …, 2021 - Mass Medical Soc
Background Despite the high efficacy of the BNT162b2 messenger RNA vaccine against
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), rare breakthrough …

Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period

SM Kissler, C Tedijanto, E Goldstein, YH Grad… - Science, 2020 - science.org
It is urgent to understand the future of severe acute respiratory syndrome–coronavirus 2
(SARS-CoV-2) transmission. We used estimates of seasonality, immunity, and cross …

[HTML][HTML] Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study

N Barda, N Dagan, C Cohen, MA Hernán, M Lipsitch… - The Lancet, 2021 - thelancet.com
Background Many countries are experiencing a resurgence of COVID-19, driven
predominantly by the delta (B. 1.617. 2) variant of SARS-CoV-2. In response, these countries …

Transmission dynamics and control of severe acute respiratory syndrome

M Lipsitch, T Cohen, B Cooper, JM Robins, S Ma… - science, 2003 - science.org
Severe acute respiratory syndrome (SARS) is a recently described illness of humans that
has spread widely over the past 6 months. With the use of detailed epidemiologic data from …

[HTML][HTML] Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China

JT Wu, K Leung, M Bushman, N Kishore, R Niehus… - Nature medicine, 2020 - nature.com
As of 29 February 2020 there were 79,394 confirmed cases and 2,838 deaths from COVID-
19 in mainland China. Of these, 48,557 cases and 2,169 deaths occurred in the epicenter …

Model-informed COVID-19 vaccine prioritization strategies by age and serostatus

KM Bubar, K Reinholt, SM Kissler, M Lipsitch, S Cobey… - Science, 2021 - science.org
Limited initial supply of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
vaccine raises the question of how to prioritize available doses. We used a mathematical …